ascendis pharma glp-1 receptor agonist Schematic illustration of monoagonists, dual agonists and triple GLP-1 Receptor Agonists as Treatments
Description
95% CI 0.310.50), MACEs (aHR 0.66
Understand causes, benefits, and practical insights to support better health and informed decisions.
The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they
GLP-1 drugs like Ozempic have transformed weight management, but concerns around muscle loss, bone density, dampened desire, and dependency are growing
This study investigates the effects of allulose, a rare sugar shown to reduce blood glucose, in a rat model of diet-induced obesity and T2D
